January 27, 2023
Seeking Alpha
Janssen: ESSA Provides an Update on its Clinical Collaboration with Janssen
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Oct. 31, 2022 /PRNewswire/ - ESSA Pharma Inc. ('ESSA', or the 'Company') (NASDAQ: EPIX), a ...
Read full article »
January 28, 2023
Pharmabiz
AstraZeneca's Covid drug, Evusheld loses US authorization due to variants
The US Food and Drug Administration (FDA) has stated that AstraZeneca's Evusheld (tixagevimab co─pack... See more »
January 27, 2023
Seeking Alpha
Novartis sees no benefit of Adakveo for sickle cell ailment in phase 3 trial
January 28, 2023
Pharmabiz
AstraZeneca's Covid drug, Evusheld loses US authorization due to variants
The US Food and Drug Administration (FDA) has stated that AstraZeneca's Evusheld (tixagevimab co─pack... See more »
CEO
Tom Heyman
Janssen is a New Jersey-based pharmaceutical firm that researches and develops medicinal products for the treatment of oncology, cardiovascular and immunology.
Read more